Question

Difficulty: HardOrdering Laboratory Tests

During a new patient intake appointment, a 46-year-old male construction worker describes a three-year history of progressive fatigue, disruptive snoring, and unrefreshing sleep. Over the past several months, he has also experienced bilateral wrist pain and numbness in his first three fingers that typically awakens him at night. His past medical history is notable for hypertension, for which he takes maximal doses of amlodipine, lisinopril, and hydrochlorothiazide without achieving targeted control. Vital signs show a blood pressure of 162/98 mm Hg and a heart rate of 78/min. Physical examination reveals a coarse facial appearance, a prominent mandible, and enlarged, doughy hands with broadened fingers. Which of the following is the most appropriate next step in diagnostic evaluation?

  1. Measurement of serum insulin-like growth factor 1 levelAnswer
  2. B
    Measurement of a random serum growth hormone level
  3. C
    Oral glucose tolerance test with growth hormone measurement
  4. D
    Magnetic resonance imaging of the pituitary gland
  5. E
    Polysomnography

Answer

Measurement of serum insulin-like growth factor 1 level
This patient's clinical presentation—featuring disruptive snoring (obstructive sleep apnea), bilateral median nerve compression (carpal tunnel syndrome), resistant hypertension, and characteristic somatic changes (coarse facial features, prominent mandible, and enlarged hands)—is highly suspicious for acromegaly. The most appropriate initial diagnostic step for suspected acromegaly is the measurement of serum insulin-like growth factor 1 (IGF-1). Unlike growth hormone (GH), which has a short half-life and is secreted in a highly pulsatile fashion, IGF-1 levels remain relatively stable throughout the day. IGF-1 provides a reliable, integrated marker of average daily GH secretion and serves as a highly sensitive initial screening tool.

Step-by-Step Solution

1
Analyze the patient's clinical presentation.
The patient exhibits obstructive sleep apnea, carpal tunnel syndrome, resistant hypertension, and somatic changes (coarse facies, jaw prominence, enlarged hands).
Identifying the unifying syndrome is essential to avoid investigating symptoms in isolation.
2
Identify the most likely underlying diagnosis.
The combination of findings is highly characteristic of acromegaly, a condition typically caused by a growth hormone-secreting pituitary adenoma.
Recognizing the pattern points the clinician toward the appropriate endocrine diagnostic pathway.
3
Determine the proper diagnostic sequencing for this condition.
The biochemical evaluation of acromegaly begins with a screening test (IGF-1), followed by a confirmatory dynamic test (OGTT with GH measurement) if the screening is abnormal, and finally localization via imaging (MRI).
Adhering to standard diagnostic algorithms prevents premature invasive or expensive testing and avoids the pitfalls of pulsatile hormone misinterpretation.

Key Concept

The initial laboratory screening test for suspected acromegaly is serum insulin-like growth factor 1 (IGF-1), not a random growth hormone level.
Rate this question